AJP - Endocrinology and Metabolism, Vol 258, Issue 6 E899-E906, Copyright © 1990 by American Physiological Society

ARTICLES

Enhancement of hepatic glycogen by gluconeogenic precursors: substrate flux or metabolic control?

J. H. Youn and R. N. Bergman
Department of Physiology and Biophysics, University of Southern California Medical School, Los Angeles 90033.

After a meal or glucose load, most carbons of hepatic glycogen are derived from gluconeogenesis. In vitro, hepatic glycogen accumulation is sluggish with glucose alone but markedly enhanced in the presence of gluconeogenic substrates. These findings conflict with the classical view that glucose is the major precursor of hepatic glycogen and have been termed the "glucose paradox." In this review, we attempt to elucidate the central mechanism underlying the glucose paradox by critically examining the in vitro data of hepatic glycogen accumulation. Our analysis is inconsistent with the current hypothesis that glucose phosphorylation is rate limiting for hepatic glycogen accumulation from glucose and that gluconeogenesis enhances glycogen accumulation primarily by increasing substrate flux to the hepatic glucose 6-phosphate pool. Instead, our analysis leads us to the conclusion that the rate-limiting step is the net incorporation of glucose 6-phosphate into glycogen, which is synergistically facilitated with glucose and gluconeogenic substrates. Thus gluconeogenic substrates are involved in the regulation of key enzyme(s) of glycogen metabolism. In addition, in the livers from fasted rats there is substantial cycling through glycogen, and that suppression of glycogen degradation may be a major mechanism in the enhancement of glycogen accumulation by gluconeogenic substrates. Thus we propose a specific hypothesis of the role of gluconeogenic substrates in glycogen metabolism (i.e., inhibition of phosphorylase), which can be tested by future studies.

This article has been cited by other articles:

				D. B. Savage, K. F. Petersen, and G. I. Shulman Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance Physiol Rev, April 1, 2007; 87(2): 507 - 520. [Abstract] [Full Text] [PDF]

				D. Azzout-Marniche, C. Gaudichon, C. Blouet, C. Bos, V. Mathe, J.-F. Huneau, and D. Tome Liver glyconeogenesis: a pathway to cope with postprandial amino acid excess in high-protein fed rats? Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1400 - R1407. [Abstract] [Full Text] [PDF]

				C. C. Greenberg, M. J. Jurczak, A. M. Danos, and M. J. Brady Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E1 - E8. [Abstract] [Full Text] [PDF]

				T. K. T. Lam, A. Carpentier, G. F. Lewis, G. van de Werve, I. G. Fantus, and A. Giacca Mechanisms of the free fatty acid-induced increase in hepatic glucose production Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E863 - E873. [Abstract] [Full Text] [PDF]

				C. Pagano, M. Granzotto, A. Giaccari, R. Fabris, R. Serra, A. M. Lombardi, G. Federspil, and R. Vettor Lactate infusion to normal rats during hyperglycemia enhances in vivo muscle glycogen synthesis Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R2072 - R2079. [Abstract] [Full Text] [PDF]

				M. Shiota, P. A. Jackson, H. Bischoff, M. McCaleb, M. Scott, M. Monohan, D. W. Neal, and A. D. Cherrington Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E868 - E879. [Abstract] [Full Text] [PDF]

				A. P. Bevan, A. Krook, J. Tikerpae, P. J. Seabright, K. Siddle, and G. D. Smith Chloroquine Extends the Lifetime of the Activated Insulin Receptor Complex in Endosomes J. Biol. Chem., October 24, 1997; 272(43): 26833 - 26840. [Abstract] [Full Text] [PDF]